(Q57569726)

English

A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology

article

Statements

A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology (English)
0 references
H. Anderson
0 references
S. Baka
0 references
L. Ashcroft
0 references
M. Nicolson
0 references
M. O'Brien
0 references
D. Dunlop
0 references
K. O'Byrne
0 references
V. Laurence
0 references
M. Snee
0 references
G. Dark
0 references
N. Thatcher
0 references
7 April 2006
0 references
17
0 references
7
0 references
1111-1119
0 references

Identifiers

0 references
0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit